The global hyperpigmentation disorder treatment market size is expected to reach around US$ 7,225.6 Mn by 2026 and is anticipated to expand at a CAGR of more than 7.2% from 2019 to 2026. Several factors are driving the global hyperpigmentation disorders treatment market such as include augmented adoption of lasers in pigmentation disorders treatment, decrease in social taboos boosting acceptance of pigmentation disorders treatment measures, and increase in prevalence of pigmentation related disorders.
The report analyzes and forecasts the hyperpigmentation disorder treatment market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of hyperpigmentation disorder treatment, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major hyperpigmentation disorder treatment companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of hyperpigmentation disorder treatment upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of hyperpigmentation disorder treatment and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global hyperpigmentation disorder treatment market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the hyperpigmentation disorder treatment market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of hyperpigmentation disorder treatment market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Companies Mentioned in Report
The report profiles the major players operating in the global hyperpigmentation disorders treatment market in terms of attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report are Bayer AG, ALLERGAN, Galderma S.A., SkinCeuticals, Pierre Fabre, EpiPharm AG, RXi Pharmaceuticals Corporation, Obagi Cosmeceuticals LLC, and Vivier Pharma.
The global hyperpigmentation disorders treatment market has been segmented as follows:
Hyperpigmentation Disorders Treatment Market, by Treatment Type
Hyperpigmentation Disorders Treatment Market, by Disease Indication
Hyperpigmentation Disorders Treatment Market, by End-user
Hyperpigmentation Disorders Treatment Market, by Geography
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Section 01: Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section 02: Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology
Section 03: Executive Summary
3.1 Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) and Distribution by Geography, 2018 and 2026
3.2 Global Hyperpigmentation Disorders Treatment Market Snapshot, 2018
3.3 Global Hyperpigmentation Disorders Treatment Market: Opportunity Map
Section 04: Market Overview
4.1 Overview
4.2 Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, 2016–2026
4.3 Global Hyperpigmentation Disorders Treatment Market Outlook
4.4 Global Hyperpigmentation Disorders Treatment Market: Porter’s Five Forces Analysis
4.5 Hyperpigmentation Disorders Treatment Market: Pipeline Analysis
4.6 Key Partnership & Acquisitions
4.7 Policies and Regulations: By Region
4.8 Disease Prevalence and Incidence Rate Globally
4.9 Global Hyperpigmentation Disorders Treatment Market: Pricing Assessment
Section 05: Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Opportunity Analysis
5.4 Opportunities
5.5 Trends
Section 06: Global Hyperpigmentation Disorders Treatment Market Analysis, by Treatment Type
6.1 Introduction
6.2 Global Hyperpigmentation Disorders Treatment Market Value Share Analysis, by Treatment Type
6.3 Hyperpigmentation Disorders Treatment Market Analysis, by Treatment Type
6.3.1 Topical Drugs
6.3.2 Laser Therapy
6.3.3 Chemical Peels
6.3.4 Microdermabrasion
6.3.5 Phototherapy
6.3.6 Others
6.4 Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment Type
Section 07: Global Hyperpigmentation Disorders Treatment Market Analysis, by Disease Indication
7.1 Introduction
7.2 Global Hyperpigmentation Disorders Treatment Market Value Share Analysis, by Disease Indication
7.3 Hyperpigmentation Disorders Treatment Market Analysis, by Disease Indication
7.3.1 Melasma
7.3.2 Post-inflammatory Hyperpigmentation
7.3.3 Solar Lentigines
7.3.4 Others
7.4 Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Disease Indication
Section 08: Global Hyperpigmentation Disorders Treatment Market Analysis, by End-user
8.1 Introduction
8.2 Global Hyperpigmentation Disorders Treatment Market Value Share Analysis, by End-user
8.3 Hyperpigmentation Disorders Treatment Market Analysis, by End-user
8.3.1 Hospitals
8.3.2 Aesthetic Clinics & Dermatology Centers
8.3.3 Others
8.4 Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by End-user
Section 09: Global Hyperpigmentation Disorders Treatment Market Analysis, by Region
9.1 Global Hyperpigmentation Disorders Treatment Market Snapshot, by Country
9.2 Global Hyperpigmentation Disorders Treatment Market Value Share Analysis, by Region
9.3 Hyperpigmentation Disorders Treatment Market Forecast, by Region
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Latin America
9.3.5 Middle East & Africa
9.4 Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Region
Section 10: North America Hyperpigmentation Disorders Treatment Market Analysis
10.1 Key Findings
10.2 North America Hyperpigmentation Disorders Treatment Market Overview
10.3 North America Market Value Share Analysis, by Treatment Type
10.4 North America Market Forecast, by Treatment Type
10.4.1 Topical Drugs
10.4.2 Laser Therapy
10.4.3 Chemical Peels
10.4.4 Microdermabrasion
10.4.5 Phototherapy
10.4.6 Others
10.5 North America Market Value Share Analysis, by Disease Indication
10.6 North America Market Forecast, by Disease Indication
10.6.1 Melasma
10.6.2 Post-inflammatory Hyperpigmentation
10.6.3 Solar Lentigines
10.6.4 Others
10.7 North America Market Value Share Analysis, by End-user
10.8 North America Market Forecast, by End-user
10.8.1 Hospitals
10.8.2 Aesthetic Clinics & Dermatology Centers
10.8.3 Others
10.9 Market Analysis, by Country
10.10 Market Value Share Analysis, by Country
10.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
10.11.1 U.S.
10.11.2 Canada
10.12 Market Attractiveness Analysis
10.12.1 By Treatment Type
10.12.2 By Disease Indication
10.12.3 By End-user
10.12.4 By Country
Section 11: Europe Hyperpigmentation Disorders Treatment Market Analysis
11.1 Key Findings
11.2 Europe Hyperpigmentation Disorders Treatment Market Overview
11.3 Europe Market Value Share Analysis, by Treatment Type
11.4 Europe Market Forecast, by Treatment Type
11.4.1 Topical Drugs
11.4.2 Laser Therapy
11.4.3 Chemical Peels
11.4.4 Microdermabrasion
11.4.5 Phototherapy
11.4.6 Others
11.5 Europe Market Value Share Analysis, by Disease Indication
11.6 Europe Market Forecast, by Disease Indication
11.6.1 Melasma
11.6.2 Post-inflammatory Hyperpigmentation
11.6.3 Solar Lentigines
11.6.4 Others
11.7 Europe Market Value Share Analysis, by End-user
11.8 Europe Market Forecast, by End-user
11.8.1 Hospitals
11.8.2 Aesthetic Clinics & Dermatology Centers
11.8.3 Others
11.9 Market Analysis, by Country
11.10 Market Value Share Analysis, by Country
11.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
11.11.1 Germany
11.11.2 France
11.11.3 U.K.
11.11.4 Italy
11.11.5 Spain
11.11.6 Rest of Europe
11.12 Market Attractiveness Analysis
11.12.1 By Treatment Type
11.12.2 By Disease Indication
11.12.3 By End-user
11.12.4 By Country
Section 12: Asia Pacific Hyperpigmentation Disorders Treatment Market Analysis
12.1 Key Findings
12.2 Asia Pacific Hyperpigmentation Disorders Treatment Market Overview
12.3 Asia Pacific Market Value Share Analysis, by Treatment Type
12.4 Asia Pacific Market Forecast, by Treatment Type
12.4.1 Topical Drugs
12.4.2 Laser Therapy
12.4.3 Chemical Peels
12.4.4 Microdermabrasion
12.4.5 Phototherapy
12.4.6 Others
12.5 Asia Pacific Market Value Share Analysis, by Disease Indication
12.6 Asia Pacific Market Forecast, by Disease Indication
12.6.1 Melasma
12.6.2 Post-inflammatory Hyperpigmentation
12.6.3 Solar Lentigines
12.6.4 Others
12.7 Asia Pacific Market Value Share Analysis, by End-user
12.8 Asia Pacific Market Forecast, by End-user
12.8.1 Hospitals
12.8.2 Aesthetic Clinics & Dermatology Centers
12.8.3 Others
12.9 Market Analysis, by Country
12.10 Market Value Share Analysis, by Country
12.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
12.11.1 China
12.11.2 Japan
12.11.3 India
12.11.4 Australia & New Zealand
12.11.5 Rest of Asia Pacific
12.12 Market Attractiveness Analysis
12.12.1 By Treatment Type
12.12.2 By Disease Indication
12.12.3 By End-user
12.12.4 By Country
Section 13: Latin America Hyperpigmentation Disorders Treatment Market Analysis
13.1 Key Findings
13.2 Latin America Hyperpigmentation Disorders Treatment Market Overview
13.3 Latin America Market Value Share Analysis, by Treatment Type
13.4 Latin America Market Forecast, by Treatment Type
13.4.1 Topical Drugs
13.4.2 Laser Therapy
13.4.3 Chemical Peels
13.4.4 Microdermabrasion
13.4.5 Phototherapy
13.4.6 Others
13.5 Latin America Market Value Share Analysis, by Disease Indication
13.6 Latin America Market Forecast, by Disease Indication
13.6.1 Melasma
13.6.2 Post-inflammatory Hyperpigmentation
13.6.3 Solar Lentigines
13.6.4 Others
13.7 Latin America Market Value Share Analysis, by End-user
13.8 Latin America Market Forecast, by End-user
13.8.1 Hospitals
13.8.2 Aesthetic Clinics & Dermatology Centers
13.8.3 Others
13.9 Market Analysis, by Country
13.10 Market Value Share Analysis, by Country
13.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
13.11.1 Brazil
13.11.2 Mexico
13.11.3 Rest of Latin America
13.12 Market Attractiveness Analysis
13.12.1 By Treatment Type
13.12.2 By Disease Indication
13.12.3 By End-user
13.12.4 By Country
Section 14: Middle East & Africa Hyperpigmentation Disorders Treatment Market Analysis
14.1 Key Findings
14.2 Middle East & Africa Hyperpigmentation Disorders Treatment Market Overview
14.3 Middle East & Africa Market Value Share Analysis, by Treatment Type
14.4 Middle East & Africa Market Forecast, by Treatment Type
14.4.1 Topical Drugs
14.4.2 Laser Therapy
14.4.3 Chemical Peels
14.4.4 Microdermabrasion
14.4.5 Phototherapy
14.4.6 Others
14.5 Middle East & Africa Market Value Share Analysis, by Disease Indication
14.6 Middle East & Africa Market Forecast, by Disease Indication
14.6.1 Melasma
14.6.2 Post-inflammatory Hyperpigmentation
14.6.3 Solar Lentigines
14.6.4 Others
14.7 Middle East & Africa Market Value Share Analysis, by End-user
14.8 Middle East & Africa Market Forecast, by End-user
14.8.1 Hospitals
14.8.2 Aesthetic Clinics & Dermatology Centers
14.8.3 Others
14.9 Market Analysis, by Country
14.10 Market Value Share Analysis, by Country
14.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
14.11.1 GCC Countries
14.11.2 South Africa
14.11.3 Rest of Middle East & Africa
14.12 Market Attractiveness Analysis
14.12.1 By Treatment Type
14.12.2 By Disease Indication
14.12.3 By End-user
14.12.4 By Country
Section 15: Competition Landscape
15.1 Competition Matrix
15.2 Hyperpigmentation Disorders Treatment Market Share Analysis, by Company (2018)
15.3 Company Profiles
15.3.1 Bayer AG
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Strategic Overview
15.3.1.5 Financial Overview
15.3.2 ALLERGAN
15.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2 Product Portfolio
15.3.2.3 SWOT Analysis
15.3.2.4 Strategic Overview
15.3.2.5 Financial Overview
15.3.3 Galderma S.A. (Nestle Skin Health S.A)
15.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.3.4 Strategic Overview
15.3.4 SkinCeuticals
15.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.4.4 Strategic Overview
15.3.5 Pierre Fabre
15.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.5.4 Strategic Overview
15.3.5.5 Financial Overview
15.3.6 EpiPharm AG
15.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.6.4 Strategic Overview
15.3.7 RXi Pharmaceuticals Corporation
15.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2 Product Portfolio
15.3.7.3 SWOT Analysis
15.3.7.4 Strategic Overview
15.3.7.5 Financial Overview
15.3.8 Obagi Cosmeceuticals LLC (Obagi medical)
15.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2 Product Portfolio
15.3.8.3 SWOT Analysis
15.3.8.4 Strategic Overview
15.3.9 Vivier Pharma
15.3.9.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2 Product Portfolio
15.3.9.3 SWOT Analysis
15.3.9.4 Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers